In Silico Characterization of a Novel Bioactive Compound derived from Psidium guajava 4-[5-(Pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine: A Potential Inhibitor for Targeting Signaling Proteins involved in Diabetes Development. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 16, n. 2, p. 180–190, 2024. DOI: 10.25004/IJPSDR.2024.160207. Disponível em: https://www.ijpsdr.com/index.php/journal/article/view/8584.. Acesso em: 18 may. 2024.